Clinical Trials
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 37–48 of 380 articles
Puma Biotechnology Inducement Awards: Strategic Talent Moves Under Nasdaq Rule 5635(c)(4)
Eli Lilly Retatrutide Phase 3: Safety Data and Competitive Implications
Pfizer's Berobenatide: Monthly Obesity Drug Shows Promise in Phase 2b
Lundbeck Advances Lu AG09222 After Phase 2 Migraine Data
Revolution Medicines' Daraxonrasib: Pancreatic Cancer Breakthrough and Beyond
Celcuity Expands VIKTORIA-2 Trial as Shares Trade Below Analyst Targets
FDA Flavored Vape Ban: Youth Risk and Pharma Implications
Opinion: I led the CDC response to the 2014 Ebola epidemic. The new outbreak needs massive
Amish Health Beliefs: Vaccines, Costs, and Pharma Strategy Insights
Friday Five: ASCO Takeaways, ADA Focus, China Deals & More – Clinical Trials
STAT+: What stripping civil service protections for thousands of federal workers will mean for HHS
Alabama Board of Medical Examiners Issues Warning on Non-FDA-Approved Peptides: What Pharma Teams Need to Know